CERE
Cerevel Therapeutics Holdings, Inc.
Director N Anthony Coles sold $2.5M of Cerevel Therapeutics Holdings, Inc.
Sold$2,533,697
$25.34Price
100,000Shares
−97%Stake
What CERE did after the filing
- The stock from Mon, Nov 6 close, $24.96
- +66.1%
- S&P 500, same days
- +9.4%
Measured over 30 trading days, to the Dec 19 close.
Traded Thu, Nov 2. Filed Mon, Nov 6, 12:12 PM ET, during the session. Returns use the Nov 6 close and the Dec 19 close. Not investment advice.